INTRODUCTION AND HYPOTHESIS: The study aims to report an extended follow-up of our case series of sacrohysteropexy for pelvic organ prolapse (POP). METHODS: Fifty-five patients with symptomatic POP underwent uterus sparing surgery. All patients were followed up for 1, 3, 6 and 12 months and then annually. Objective success was defined as a well-supported cervix and no vaginal prolapse stage ≥ 2. Subjective success was no prolapse-related symptoms or voiding disorder. RESULTS: The mean follow-up was 60 ± 34 months. Anterior compartment prolapse (cystocele) stage ≥ 2 was present in four out of 52 patients (7.7%), while posterior compartment prolapse (rectocele) stage ≥ 2 was present in three (5.7%). Voiding symptoms were resolved in 42 out of 45 patients (93.4%) and storage symptoms in 30 out of 36 (83.3%); one patient reported de novo urgency. Sexual activity was maintained in 28 out of 29 patients (95.5%). Four patients showed de novo stress urinary incontinence. CONCLUSION: Our findings support the use of uterus preservation, with significative objective and subjective outcomes in treating POP.
INTRODUCTION AND HYPOTHESIS: The study aims to report an extended follow-up of our case series of sacrohysteropexy for pelvic organ prolapse (POP). METHODS: Fifty-five patients with symptomatic POP underwent uterus sparing surgery. All patients were followed up for 1, 3, 6 and 12 months and then annually. Objective success was defined as a well-supported cervix and no vaginal prolapse stage ≥ 2. Subjective success was no prolapse-related symptoms or voiding disorder. RESULTS: The mean follow-up was 60 ± 34 months. Anterior compartment prolapse (cystocele) stage ≥ 2 was present in four out of 52 patients (7.7%), while posterior compartment prolapse (rectocele) stage ≥ 2 was present in three (5.7%). Voiding symptoms were resolved in 42 out of 45 patients (93.4%) and storage symptoms in 30 out of 36 (83.3%); one patient reported de novo urgency. Sexual activity was maintained in 28 out of 29 patients (95.5%). Four patients showed de novo stress urinary incontinence. CONCLUSION: Our findings support the use of uterus preservation, with significative objective and subjective outcomes in treating POP.
Authors: Paul Abrams; Linda Cardozo; Magnus Fall; Derek Griffiths; Peter Rosier; Ulf Ulmsten; Philip van Kerrebroeck; Arne Victor; Alan Wein Journal: Neurourol Urodyn Date: 2002 Impact factor: 2.696
Authors: R C Bump; A Mattiasson; K Bø; L P Brubaker; J O DeLancey; P Klarskov; B L Shull; A R Smith Journal: Am J Obstet Gynecol Date: 1996-07 Impact factor: 8.661
Authors: Ingrid E Nygaard; Rebecca McCreery; Linda Brubaker; AnnaMarie Connolly; Geoff Cundiff; Anne M Weber; Halina Zyczynski Journal: Obstet Gynecol Date: 2004-10 Impact factor: 7.661
Authors: Kate V Meriwether; Ethan M Balk; Danielle D Antosh; Cedric K Olivera; Shunaha Kim-Fine; Miles Murphy; Cara L Grimes; Ambereen Sleemi; Ruchira Singh; Alexis A Dieter; Catrina C Crisp; David D Rahn Journal: Int Urogynecol J Date: 2019-02-11 Impact factor: 2.894